Article
Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals.
Science translational medicine - 27 Jan 2021
Kim Sang Il, Noh Jinsung, Kim Sujeong, Choi Younggeun, Yoo Duck Kyun, Lee Yonghee, Lee Hyunho, Jung Jongtak, Kang Chang Kyung, Song Kyoung-Ho, Choe Pyoeng Gyun, Kim Hong Bin, Kim Eu Suk, Kim Nam-Joong, Seong Moon-Woo, Park Wan Beom, Oh Myoung-Don, Kwon Sunghoon, Chung Junho
Abstract excerpt
Stereotypic antibody clonotypes exist in healthy individuals and may provide protective immunity against viral infections by neutralization. We observed that 13 of 17 patients with COVID-19 had stereotypic variable heavy chain (VH) antibody clonotypes directed against the receptor binding domain (RBD) of SARS-CoV-2 spike protein. These antibody clonotypes were composed of immunoglobulin heavy variable 3-53...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
